Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer.

Date publication

février 2009

Journal

Gynecologic oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles

Tous les auteurs :
Ballester M, Rouzier R, Coutant C, Kerrou K, Daraï E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/19081610

Résumé

Lymph node status in endometrial cancer is a major prognostic factor. Sentinel lymph node (SLN) biopsy using radiocolloid and blue dye labeling has emerged as an alternative to systematic lymphadenectomy. This technique requires a preoperative lymphoscintigraphy. The aim of this study was to evaluate the limits of day-before preoperative lymphoscintigraphy to SLN biopsy.

Mots clés

Aged, Aged, 80 and over, Brachytherapy, Endometrial Neoplasms, diagnostic imaging, Female, Humans, Lymph Nodes, diagnostic imaging, Lymphatic Metastasis, Middle Aged, Preoperative Care, Radionuclide Imaging, methods, Radiopharmaceuticals, Retrospective Studies, Sentinel Lymph Node Biopsy, methods, Technetium Tc 99m Sulfur Colloid

Référence

Gynecol. Oncol.. 2009 Feb;112(2):348-52